NET PROFIT (x1000 DKK)
EMPLOYEES
Fisher Scientific Biotech Line A/S
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
10,232
|
125,145
|
-6,860 |
Total assets |
12,389,676
|
7,910,834
|
8,020,509 |
Current assets |
38,361
|
34,942
|
144,591 |
Current liabilities |
76,845
|
69,652
|
515,665 |
Equity capital |
12,312,831
|
7,841,182
|
7,504,844 |
- share capital |
502
![]() |
502
![]() |
502 |
Employees (average) |
15
![]() |
15
![]() |
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
99.4%
|
99.1%
|
93.6% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
49.9%
|
50.2%
|
28.0% |
Return on equity (ROE) |
0.1%
|
1.6%
|
-0.1% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.